Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Evogene Ltd. - Ordinary Shares
(NQ:
EVGN
)
1.060
-0.020 (-1.85%)
Streaming Delayed Price
Updated: 12:33 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Evogene Ltd. - Ordinary Shares
< Previous
1
2
3
Next >
Climateflation and Water Scarcity: A Global Food Crisis with Dire Implications for Africa
December 12, 2025
The world is currently grappling with a potent and dangerous cocktail of climate change impacts and water scarcity, giving rise to a phenomenon dubbed "climateflation." This escalating crisis is...
Via
MarketMinute
Topics
Artificial Intelligence
Climate Change
Economy
What's Next: Evogene's Earnings Preview
↗
November 19, 2025
Via
Benzinga
Evogene Ltd (NASDAQ:EVGN) Reports Mixed Q2 2025 Results, Beats EPS Estimates But Misses on Revenue
↗
August 19, 2025
Evogene (EVGN) reported Q2 2025 results, missing revenue estimates but beating on EPS. The stock saw a modest pre-market gain as investors focused on the narrower-than-expected loss.
Via
Chartmill
Preview: Evogene's Earnings
↗
August 18, 2025
Via
Benzinga
Insights into Evogene's Upcoming Earnings
↗
May 20, 2025
Via
Benzinga
A Glimpse of Evogene's Earnings Potential
↗
November 20, 2024
Via
Benzinga
Earnings Scheduled For November 20, 2025
↗
November 20, 2025
Via
Benzinga
Earnings Scheduled For August 19, 2025
↗
August 19, 2025
Via
Benzinga
Evogene Earnings Preview
↗
March 06, 2024
Via
Benzinga
Recap: Evogene Q3 Earnings
↗
November 15, 2023
Via
Benzinga
A Preview Of Evogene's Earnings
↗
November 14, 2023
Via
Benzinga
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud
↗
June 10, 2025
The company said its internal tests show a nearly 90% success in generating precise, novel molecules, vastly outperforming traditional generative AI models.
Via
Stocktwits
Topics
Artificial Intelligence
Top movers in Tuesday's after hours session
↗
June 10, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Dow Gains 50 Points; US Small Business Optimism Index Rises In May
↗
June 10, 2025
Via
Benzinga
Topics
Stocks
Which stocks are moving on Tuesday?
↗
June 10, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Which stocks are gapping on Tuesday?
↗
June 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results
↗
June 10, 2025
Via
Benzinga
These stocks that are showing activity before the opening bell on Tuesday.
↗
June 10, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
Earnings Scheduled For May 21, 2025
↗
May 21, 2025
Via
Benzinga
Unusual volume stocks in Tuesday's session
↗
April 22, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI
↗
April 21, 2025
Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals.
Via
Benzinga
Earnings Scheduled For March 6, 2025
↗
March 06, 2025
Via
Benzinga
Earnings Scheduled For November 21, 2024
↗
November 21, 2024
Via
Benzinga
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
↗
August 22, 2024
EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
↗
May 23, 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
↗
March 07, 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
↗
March 07, 2024
Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported...
Via
Benzinga
Topics
Cannabis
Earnings Scheduled For March 7, 2024
↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
↗
November 16, 2023
Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech.
Via
Benzinga
Topics
Cannabis
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
↗
October 02, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
